Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001642247-16-000010

CEO bought 20,000 shares at $0.60 ($12,000)

From the SEC's structured data for this filing

Trades in this filing

LAVOY THOMAS C · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-11-17 Purchase : show line 1 in the form +20,000 $0.60 $12,000 163,523 D
Open-market purchases · 20,000 sh · avg $0.60 · $12,000
Loading xslF345X03/primary_doc.xml…